Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer

NCT00383487 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT00383487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00383487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer
Lead sponsor
Stanford University
Phase
Phase 2
Overall status
Terminated
Start date
March 31, 2005
Completion date
July 31, 2007
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer, prostatic neoplasms